Table 4.
Risk factors for severe sleep disturbance among patients who received dexmedetomidine therapy under general anesthesia and non-general anesthesia in a stepwise logistic regression analysis model.
| Population | Factors with statistical significance | P-value | OR | 95% CI | Model P-value |
|---|---|---|---|---|---|
| General anesthesia (n = 2,050) | <0.001 | ||||
| Intraoperative dexmedetomidine dose (Ref. High-DEX) | <0.001 | 0.39 | 0.27–0.57 | ||
| Surgery type (Ref. other type surgery) | |||||
| Abdominal surgery | 0.369 | 0.38 | 0.56–1.24 | ||
| Orthopedic surgery | <0.001 | 1.93 | 1.37–2.72 | ||
| Urological surgery | 0.527 | 0.85 | 0.52–1.40 | ||
| Non-general anesthesia (n = 925) | 0.022 | ||||
| Intraoperative dexmedetomidine dose (Ref. High-DEX) | 0.026 | 0.59 | 0.37–0.94 | ||
| Receiving PCIA (Ref. yes) | 0.002 | 2.22 | 1.34–3.69 |
OR, odds rate; CI, confidence interval; PCIA, patient-controlled intravenous analgesia; Ref., reference.